NHS National Pharmaceuticals Transition 2022_1
Estimated value
—
Awarded value
—
Suppliers
60
Lots
3
Published
12 Aug 2022
Description
NHS National Pharmaceuticals Transition 2022_1<br/>Potential periods of call-offs under the<br/>framework agreement:<br/>Transition:<br/>CESW: 29/07/2022 to 30/09/2023 (14<br/>months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22<br/>months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6months)<br/>Oral (plus non-parenteral) Products: All<br/>regions: 29/07/2022 to 31/05/2024 (22<br/>months)<br/>Hospital Only Products:<br/>CESW: 29/07/2022 to 30/09/2023 (14<br/>months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22<br/>months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6<br/>months)
Scope
- Reference
- CM/PHG/21/5637
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2022 to 31 May 2024
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 60 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 3 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Lot 1 - CM/PHG/21/5637/00 Transition products | £397.8m | cancelled |
| 2 | Lot 2 - CM/PHG/21/5637/01 Oral (plus non-parenteral) products | £12.3m | cancelled |
| 3 | Lot 3 - CM/PHG/21/5637/02 Hospital Only Products | £57.9m | cancelled |